Biologic Regulatory Affairs

The Biologic Regulatory Affairs Online Certification Course from ROYED Training is designed to deliver a seamless, practical learning experience through advanced interactive e-learning tools. As a result, learners gain hands-on exposure to real-world regulatory scenarios, biotech development pathways, and global submission processes—anytime, anywhere.

A Modular, Practice-Driven Learning Path

This program is structured into modular sections, each covering essential domains of modern biologic regulation. Moreover, every module is enriched with case studies, simulations, quizzes, and scenario-based exercises, enabling you to immediately apply the concepts learned.

Key module themes include:

• Innovator biologic and biosimilar regulations
• Global regulatory approval pathways
• Clinical development and evidence requirements
• Biosimilar comparability and characterization studies
• Biologic CMC, process development, and quality strategy
• Biotech business development and commercialization insights

Together, these modules deliver a strong, industry-aligned understanding of the entire biologic lifecycle—from R&D and manufacturing to registration and market management.

Major Focus Areas of the Biologic Regulatory Affairs Course

The course places significant emphasis on how innovator biologics and biosimilars are researched, developed, manufactured, and regulated across global markets. Therefore, participants gain an end-to-end perspective of:

• Biotech R&D and preclinical/clinical development
• Upstream and downstream manufacturing processes
• Regulatory pathways for biologics and biosimilars
• Strategic decisions in global registration and post-approval lifecycle management
• Commercialization, market readiness, and strategic planning

Because the curriculum incorporates real-life simulations and decision-making exercises, learners are trained to think like regulatory professionals in leading biotech organizations.

A Realistic, Career-Ready Training Experience

This online certification goes far beyond theory. It focuses on building regulatory affairs strategic management skills, ensuring that learners acquire the competencies required for effective performance in biotech, biologic manufacturing, and biosimilar companies.

Furthermore, the course includes advanced interactive tools such as:

• Practical simulations mimicking regulatory job functions
• Reflection questions to deepen conceptual understanding
• Real-world dossier preparation examples
• Expert live chat for continuous support
• Interactive exercises that reinforce every learning milestone

Consequently, participants complete the program with confidence—equipped to handle regulatory submissions, compliance expectations, and biologic product strategies in fast-evolving global markets.

Key features of the course

• Full Self-Paced Learning – Accessible 24×7 from any device (desktop, mobile, tablet).
• Real-Life Job Simulation – Hands-on learning with biotech CMC dossiers, eCTD workflows, manufacturing case studies, and regulatory strategy modules.
• Global Regulatory Pathways – US FDA, EMA, MHRA, PMDA, TGA, GCC, ASEAN, India, LATAM, Africa, and other emerging markets.
• Future-Ready Skills – Exposure to AI-enabled regulatory frameworks, predictive compliance tools, and automated documentation systems.
• Certificate Awarded Upon Successful Completion.

Who should attend the course?

Learning Outcome

After successful completion, participants will be able to:

• Understand and interpret global biologic and biosimilar regulations
• Prepare, review, and manage CMC documentation for biologics
• Use AI tools to optimize regulatory submissions & documentation workflows
• Develop global submission strategies for innovator biologics & biosimilars
• Evaluate comparability, QbD, validation & advanced analytical data
• Navigate regulatory audits, inspections, and compliance expectations

Few of the similar courses 

• Drug Biologic Medical Device Regulatory Affairs
• Biopharmaceutical Project Management
• Drug Regulatory Affairs
• Biopharma Medical Representative Training
• Pharma Strategic Management
• Drug Registration and Regulation in China
• GMP and GMP audit training
• Valuation technique in biotech industry
• Basics of biopharmaceutical
• Pharma Business Development and Licensing

Career in Regulatory Affairs department in a biologic company

A career in biologic regulatory affairs involves working in a field that focuses on ensuring compliance with regulations and guidelines related to the development, approval, and post-marketing activities of biologic products. Biologic products include vaccines, gene therapies, blood products, and other treatments derived from living organisms.

Role and Key Responsibilities of the Biologic Regulatory Affairs professional

Regulatory Compliance

Regulatory affairs professionals in the biologic industry are responsible for understanding and interpreting regulations and guidelines set forth by regulatory authorities. They ensure that biologic products and their associated documentation meet all necessary requirements.

Product Registration and Approval

Regulatory affairs professionals play a crucial role in the submission and approval process for biologic products. They prepare and submit regulatory applications, including investigational new drug (IND) applications, biologics license applications (BLAs), and marketing authorization applications (MAAs). They work closely with cross-functional teams, including researchers, clinicians, and manufacturing experts, to gather and compile the necessary data and documentation for submissions.

Regulatory Strategy

There is no doubt of the fact that Developing a regulatory strategy is an important aspect of regulatory affairs. Certainly, professionals in this field provide strategic guidance to ensure that product development plans align with regulatory requirements. For instance, they assess the regulatory landscape, anticipate potential challenges first. Further they will develop strategies to address them. Hence, this involves staying up to date with the latest regulatory developments and industry trends.

Labeling and Advertising

Regulatory affairs professionals ensure that product labeling and advertising materials comply with regulatory guidelines. For instance, they are responsible for review and approve labeling content, including package inserts, patient information leaflets, and promotional materials. Therefore this will ensure accuracy and compliance of the biologics.

Post-Marketing Compliance

Once a biologic product is approved and on the market, regulatory affairs professionals monitor post-marketing activities to ensure ongoing compliance with regulatory requirements. In fact they manage post-approval submissions, track adverse events. In addition, they ensure timely reporting to regulatory authorities. They also stay updated on changes to regulations and guidelines that may impact post-marketing activities.

Liaison with Regulatory Authorities

Above all, regulatory affairs professionals serve as a point of contact between the biologic company and regulatory authorities. They may participate in meetings with regulatory agencies, address queries or requests for additional information, and represent the company’s interests during regulatory inspections or audits.

Qualification and skill required for Biologic Regulatory Affairs Professionals

• To pursue a career in biologic regulatory affairs, a background in life sciences, pharmacy, or a related field is typically required.
• Many regulatory affairs professionals also hold advanced degrees, such as a Master’s or even higher.
• Above all, strong attention to detail, knowledge of regulatory guidelines, excellent communication skills, and the ability to work in cross-functional teams are important qualities for success in this field.
• In fact, PG Certification Biologic regulatory affairs (PGBRA) course will enhance your acceptance of your candidature as the course provides hands on training on Biologic and Biosimilar regulation, registration and strategic planning process.

Periodic update is the key for Biologic Regulatory professionals

• Above all, biologic regulations and requirements can vary between countries and regions. Therefore, familiarity with the specific regulatory environment of the target market is essential. Additionally, staying up to date with evolving regulations and guidelines is crucial to effectively navigate the dynamic regulatory landscape in the biologic industry. In this regard, PG Certification Biologic regulatory affairs (PGBRA) plays a forehand role to keep user informed about the changing guideline of biologic industry.

Biopharma Basics

• Introduction to Global biopharmaceutical Industry.
• Biotech Drug Development Process. Overview of the development of a biotech product – clarify the difference between synthetic drugs, biologics and biotech products.
• Biotech Drugs Classification. Important classes.
• Detailed understanding on different types biologics. For example, Monoclonal Antibody, Interferon, Erythropoiesis Stimulating Agents and other important biologic.
• Advanced Therapy Medicinal Products (ATMPs).
• Key Understanding on biotech regulation. Topics include understanding the differences in regulatory philosophy between small molecules and biotech product regulation.
• Preclinical and Clinical Research Design.

Regulatory Pathway

• Innovator biopharmaceutical regulation, registration process.
• Biosimilar Development and regulation. Topics include Introduction to Biosimilar.
• Meaning of Biosimilar vs. Follow on biologics.
• Subsequently Difference between biosimilar and generic drugs.
• Biosimilar Approval Pathways
• Key important issues in Biotech and biosimilar product manufacturing. Insight on biosimilar approval pathway.

Biologic CMC writing and management 

• Biologics Product Characteristics and Regulatory Implications
• Quality By Design
• QbD and TPP
• Comparability of biologic products
• CMC strategic planning for various types of the biologics
• Documentation requirements

Biologic Manufacturing 

• GMP requirements for Biologic Products.
• Biologic and Biosimilar manufacturing process.
• Plant audits, warning letters, CRL.

Advance Strategic Management 

• Topics include regulatory submission, approval, production, and the postmarket environment for both drugs and devices. Challenges surrounding the approval and naming of follow-on biologics are addressed. Above all, course discussion covers the stages of a drug pipeline and risk assessment at each marketing authorization stages.
• Analytical techniques for the Biotech Drugs. Understand the need for using a range of analytical methods in the characterization of biotech product.
• Global Biotechnology Business. Discussion also covers domestic and International business considerations and international regulatory requirements. Moreover, course provide the access to case studies related to biologic strategic management.

Country specific guidelines

• Biologic regulations in US, EU, LATAM, Middle East / GCC, LATAM, Japan, ASEAN, India and ROW market.

AI in Regulatory Affairs for Biologics (Newly Added Module)

• Role of AI and ML in modern regulatory functions
• AI-assisted CMC authoring
• AI-driven dossier structuring, gap analysis & risk prediction
• Automation for Module 3 (Quality) documentation
• AI-supported labeling review & harmonization
• Using AI tools for:
  • Regulatory intelligence
  • Change control prediction
  • Stability data interpretation
  • Manufacturing deviation pattern detection
• Case studies on AI-enabled submission management